v3.22.4
Equity
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangements [Abstract]  
Equity Equity:
Share-based compensationDecember 31, 2022December 31, 2021
Option Expense$6,101 $6,093 
DSU Expense529 672 
RSU Expense2,778 2,904 
Total share-based compensation$9,408 $9,669 
(a)Share capital:
Upon acquisition of Ballard Motive Solutions in November 2021 (note 7), part of the total consideration of $39,917,000 included the issuance of 337,353 shares of the Corporation in three future tranches at a fair value of $18.30 per share discounted for the timing delay in receiving the shares using an Asian put option pricing model, or $4,851,000.
During the year ended December 31, 2022, the Corporation issued the first tranche of 112,451 common shares with a fair value of $1,782,000 as per the acquisition date, offset by miscellaneous deferred financing costs of $20,000.
On February 23, 2021, the Corporation completed a bought deal offering with a syndicate of financial institutions for 14,870,000 shares of the Corporation at $37.00 per share, resulting in gross offering proceeds of $550,190,000 and net offering proceeds of $527,291,000.
Shares Transacted14,870,000 
Average Share Price$37.00 
Gross offering proceeds$550,190 
Less: Underwriting expenses(22,186)
Less: Other financing expenses(713)
Net offering proceeds$527,291 
During March 2021, the Corporation filed a short form base Shelf Prospectus, which provides the flexibility to make offerings of securities up to an aggregate initial offering price of $1,500,000,000 during the effective period of the Prospectus, until April 2023.
At December 31, 2022, 298,394,203 ( 2021 - 297,700,295) common shares were issued and outstanding.
(b)    Share options:
The Corporation has options outstanding under a consolidated share option plan. All directors, officers and employees of the Corporation, and its subsidiaries, are eligible to participate in the share option plans although as a matter of policy, options are currently not issued to directors. Option exercise prices are denominated in either Canadian or U.S. dollars, depending on the residency of the recipient. Canadian dollar denominated options have been converted to U.S. dollars using the year-end exchange rate for presentation purposes.
All options have a term of seven years from the date of grant unless otherwise determined by the board of directors. One-third of the options vest and may be exercised, at the beginning of each of the second, third, and fourth years after granting.
21.     Equity (cont'd):
(b)    Share options (cont'd):
As at December 31, options outstanding from the consolidated share option plan were as follows:
BalanceOptions for common sharesWeighted average exercise price
At January 1, 20214,149,639 $7.07 
Options granted540,116 21.12 
Options exercised(549,281)4.33 
Options forfeited(98,907)10.09 
Options expired— — 
At December 31, 20214,041,567 8.70 
Options granted1,263,685 8.97 
Options exercised(304,635)2.87 
Options forfeited(184,496)12.75 
Options expired(8,501)2.20 
At December 31, 20224,807,620 $9.00 
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2022:
Options outstandingOptions exercisable
NumberWeighted average
remaining
contractual life
Weighted
average
exercise
NumberWeighted
average
Range of exercise priceoutstanding(years)priceexercisableexercise price
$1.33 - $3.06
1,174,815 2.6$2.69 1,174,815 $2.69 
$3.56 - $5.50
484,493 3.34.04 389,085 3.68 
$6.92 - $10.64
2,226,069 5.29.87 721,156 10.51 
$12.63 - $26.13
922,243 5.117.53 455,966 16.66 
4,807,620 4.3$9.00 2,741,022 $7.21 
During 2022, compensation expense of $6,101,000 (2021 – $6,093,000) was recorded in net loss based on the grant date fair value of the awards recognized over the vesting period.
During 2022, 304,635 options were exercised for an equal amount of common shares for proceeds of $916,000. During 2021, 549,281 options were exercised for an equal amount of common shares for proceeds of $2,415,000.
During 2022, options to purchase 1,263,685 common shares were granted with a weighted average fair value of $4.92 (2021 – 540,116 options and $10.76 fair value). The granted options vest annually over three years.
The fair values of the options granted were determined using the Black-Scholes valuation model under the following weighted average assumptions:
20222021
Expected life4 years4 years
Expected dividendsNilNil
Expected volatility69 %67 %
Risk-free interest rate%%
As at December 31, 2022, options to purchase 4,807,620 common shares were outstanding (2021 – 4,041,567).
21.     Equity (cont'd):
(c)    Share distribution plan:
The Corporation has a consolidated share distribution plan that permits the issuance of common shares for no cash consideration to employees of the Corporation to recognize their past contribution and to encourage future contribution to the Corporation. At December 31, 2022, there were 18,844,127 (2021 – 19,540,514) shares available to be issued under this plan.
During 2021 and 2022, no shares were issued under this plan and therefore no compensation expense was recorded against profit or loss.
(d)    Deferred share units:
Deferred share units (“DSUs”) are granted to the board of directors and executives. Eligible directors must elect to receive at least half of their annual retainers and executives may elect to receive all or part of their annual bonuses in DSUs. Each DSU is redeemable for one common share in the capital of the Corporation after the director or executive ceases to provide services to the Corporation. Shares will be issued from the Corporation’s share distribution plan.
BalanceDSUs for common shares
At January 1, 2021820,031 
DSUs granted35,953 
DSUs exercised(99,761)
At December 31, 2021756,223 
DSUs granted80,319 
DSUs exercised(126,862)
At December 31, 2022709,680 
During 2022, compensation expense of $529,000 (2021 - $672,000) was recorded in net loss relating to 80,319 DSUs (2021 - 35,953) granted during the year.
During 2022, 126,862 DSUs (2021 – 99,761) were exercised, net of applicable taxes, which resulted in the issuance of 58,990 common shares (2021 – 46,388), resulting in an impact on equity of $753,000 (2021 - $1,290,000).
As at December 31, 2022, 709,680 deferred share units were outstanding (2021 – 756,223).
(e)    Restricted share units:
Restricted share units (“RSUs”) are granted to employees and executives. Each RSU is convertible into one common share. The RSUs vest after a specified number of years from the date of issuance, and under certain circumstances, are contingent on achieving specified performance criteria. A performance factor adjustment is made if there is an over-achievement (or under-achievement) of specified performance criteria, resulting in additional (or fewer) RSUs being converted.
The Corporation has two plans under which RSUs may be granted, the consolidated share distribution plan and the market purchase RSU plan. Awards under the consolidated share distribution plan are satisfied by the issuance of treasury shares on maturity.
21.     Equity (cont'd):
(e)    Restricted share units (cont'd):
BalanceRSUs for common shares
At January 1, 20211,129,946 
RSUs granted195,838 
RSU performance factor adjustment(12,128)
RSUs exercised(325,863)
RSUs forfeited(21,573)
At December 31, 2021966,220 
RSUs granted567,693 
RSU performance factor adjustment(29,004)
RSUs exercised(460,681)
RSUs forfeited(42,148)
At December 31, 20221,002,080 
During 2022, compensation expense of $2,778,000 (2021 - $2,904,000) was recorded in net loss.
During 2022, 567,693 RSUs were issued (2021 – 195,838). The fair value of RSU grants is measured based on the stock price of the shares underlying the RSU on the date of grant.
During 2022, 460,681 RSUs (2021 – 325,863) were exercised, net of applicable taxes, which resulted in the issuance of 217,832 common shares (2021 – 156,449), resulting in an impact on equity of $2,466,000 (2021 - $4,357,000).
As at December 31, 2022, 1,002,080 RSUs were outstanding (2021 – 966,220).